Minimally INvasive Colon Cancer Surgery Through IMmunomics and Optical Mapping of the Sentinel Lymph Node.

The project investigates the feasibility of laparoscopic fluorescent imaging for the intraoperative detection of the sentinel lymph node (SLN) in colon cancer patients. In addition, the topology of immunological and microenvironmental changes in normal and invaded lymph nodes (LN's) will be correlated to the LN location (anatomical mapping).

Trial Details

NCT ID
NCT03779009
Phase
NA
Sponsor
University Hospital, Ghent
Status
RECRUITING
Cancer Type
Colorectal Cancer
Interventions
  • ICG-nanocoll (indocyanine green coupled to the human albumin colloidal particle nanocoll)
Locations (sample)
  • Ghent, Belgium|51.05,3.71667

Key Eligibility Criteria

  • Tumor type: proven adenocarcinoma of the colon
  • Extent of disease (AJCC 7th edition): clinically node negative (stage II) non-metastatic colon cancer
  • Locally resectable disease
  • Adequate mental faculty, allowing to understand the proposed treatment protocol and provide informed consent

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colorectal Cancer Trials on Trialify →